Efferalgan and aspartate aminotransferase increased Patient Reports February 11, 2012
Efferalgan Side Effects Report #5040746-8
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, aspartate aminotransferase increased, asthenia, cardiomyopathy
, dizziness
, dyspnoea, face oedema, haemoglobin decreased. Efferalgan dosage: unknown. Patient was hospitalized. Patient recovered.Efferalgan Side Effects Report #5058440-6
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, cardiomyopathy
, dizziness
, dyspnoea, face oedema. Efferalgan dosage: unknown. Patient was hospitalized. Patient recovered.Efferalgan Side Effects Report #5145963-4
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, aspartate aminotransferase increased, asthenia, atrial fibrillation
, cardiogenic shock, cardiomyopathy
, dizziness
, dyspnoea. Efferalgan dosage: unknown. During the same period patient was treated with EXJADE. Patient was hospitalized. Patient recovered.Efferalgan Side Effects Report #5157076-6
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, aspartate aminotransferase increased, asthenia, atrial fibrillation
, cardiac failure, cardiogenic shock, cardiomyopathy
, dizziness
. Efferalgan dosage: unknown. During the same period patient was treated with EXJADE. Patient was hospitalized. Patient died on 11/19/2006.Efferalgan Side Effects Report #5028403-5
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, aspartate aminotransferase increased, asthenia, dizziness
, face oedema, haemoglobin decreased, headache
, nausea
. Efferalgan dosage: unknown. Patient was hospitalized. Patient recovered.Efferalgan Side Effects Report #5028638-1
Efferalgan side effect was reported by a Physician from FRANCE on June 08, 2006. Male patient, 21 years of age, weighting 92.59 lb, was diagnosed with headache
, blood iron increased and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase, aspartate aminotransferase increased, asthenia, dizziness
, face oedema, haemoglobin decreased, headache
, nausea
. Efferalgan dosage: unknown. Patient was hospitalized. Patient recovered.Efferalgan Side Effects Report #4853672-1
Efferalgan side effect was reported by a Health Professional from FRANCE on Dec 06, 2005. Male patient, 45 years of age, was diagnosed with knee operation and was treated with Efferalgan. After drug was administered, patient experienced the following side effects: agranulocytosis, alanine aminotransferase increased, aspartate aminotransferase increased. Efferalgan dosage: unknown. During the same period patient was treated with AMIKIN, AXEPIM, MYOLASTAN, MOPRAL. Patient was hospitalized. Patient recovered.
Efferalgan and aspartate aminotransferase increased 